Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Prostatic Neoplasms 3Vasculitis 1Neoplasms 1Lupus Erythematosus, Systemic 1Leukemia, Myeloid, Acute 1Glomerulonephritis 1Colorectal Neoplasms 1Colonic Neoplasms 1COVID-19 1Adenomatous Polyposis Coli 1

Interventions

Celecoxib 4Ursodeoxycholic Acid 2Sulindac 2Sirolimus 2Curcumin 2Biopsy 2Thiamine 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Suppositories 1Sigmoidoscopy 1Probiotics 1Pharmaceutical Preparations 1Niclosamide 1Metformin 1Magnetic Resonance Spectroscopy 1Lithium Carbonate 1Inulin 1Immunohistochemistry 1Gastroscopy 1Exercise Therapy 1Erlotinib Hydrochloride 1Endoscopy, Digestive System 1Endoscopy 1Educational Status 1Duodenoscopy 1Colonoscopy 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Adenomatous Polyposis Coli × Niclosamide × Clear all
NCT04296851 2020-03-05

Niclosamide for Familial Adenomatous Polyposis

Yonsei University

Phase 2 Unknown
72 enrolled
Gastrointestinal

Adenomatous Polyposis Coli

Data powered by HemOnc (CC BY 4.0) Colophon âš¡